Table 3 Acute and late treatment-related toxicity
Acute treatment-related toxicity | Late treatment-related toxicity | |||||||
|---|---|---|---|---|---|---|---|---|
Side effect | low grade (CTCAE I-II) | high grade (CTCAE III or higher) | low grade (CTCAE I-II) | high grade (CTCAE III or higher) | ||||
n= | % | n= | % | n= | % | n= | % | |
focal alopecia | 70 | 63.6% | 0 | 0.0% | 1 | 0.9% | 0 | 0.0% |
fatigue | 52 | 47.3% | 0 | 0.0% | 10 | 9.1% | 1 | 0.9% |
skin irritation | 44 | 40.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
headache | 25 | 22.7% | 0 | 0.0% | 10 | 9.1% | 0 | 0.0% |
nausea | 23 | 20.9% | 1 | 0.9% | 0 | 0.0% | 0 | 0.0% |
facial pain | 12 | 10.9% | 0 | 0.0% | 2 | 1.8% | 0 | 0.0% |
dysgeusia | 8 | 7.3% | 0 | 0.0% | 4 | 3.6% | 0 | 0.0% |
lymphedema | 7 | 6.4% | 0 | 0.0% | 3 | 2.7% | 0 | 0.0% |
xerostomia | 5 | 4.5% | 0 | 0.0% | 4 | 3.6% | 0 | 0.0% |
mucositis | 1 | 0.9% | 1 | 0.9% | 1 | 0.9% | 0 | 0.0% |
radionecrosis | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 3 | 2.7% |